home / stock / inrlf / inrlf short
Short Information | Valneva Se Ord (OTCMKTS:INRLF)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 35,405 |
Total Actual Volume | 41,054 |
Short Trends | |
---|---|
Cover Days | 3 |
Short Days | 17 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 1,770 |
Average Short Percentage | 81.19% |
Is there a INRLF Short Squeeze or Breakout about to happen?
See the INRLF Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-12-2024 | $3.7 | $3.7 | $3.7 | $3.7 | 500 | 500 | 100% |
07-05-2024 | $3.39 | $3.39 | $3.39 | $3.39 | 255 | 255 | 100% |
06-14-2024 | $3.595 | $3.5 | $3.595 | $3.5 | 440 | 20 | 4.55% |
06-10-2024 | $4 | $4 | $4 | $4 | 7,700 | 7,700 | 100% |
06-03-2024 | $4.62 | $4.56 | $4.62 | $4.55 | 2,200 | 100 | 4.55% |
05-15-2024 | $4.34 | $4.5 | $4.5 | $4.34 | 200 | 200 | 100% |
05-14-2024 | $3.92 | $4.04 | $4.095 | $3.92 | 12,894 | 10,769 | 83.52% |
05-13-2024 | $3.75 | $3.75 | $3.75 | $3.75 | 8,846 | 8,846 | 100% |
05-10-2024 | $0 | $3.48 | $0 | $0 | 1 | 1 | 100% |
04-30-2024 | $3.76 | $3.48 | $3.76 | $3.48 | 666 | 552 | 82.88% |
04-11-2024 | $4.25 | $4.25 | $4.25 | $4.25 | 1,965 | 1,965 | 100% |
03-12-2024 | $3.863 | $3.863 | $3.863 | $3.863 | 250 | 250 | 100% |
03-11-2024 | $3.6 | $3.7 | $3.7 | $3.6 | 1,325 | 1,000 | 75.47% |
03-08-2024 | $3.75 | $3.75 | $3.75 | $3.75 | 1,002 | 1,002 | 100% |
03-06-2024 | $0 | $3.47 | $0 | $0 | 75 | 75 | 100% |
03-04-2024 | $3.47 | $3.47 | $3.47 | $3.47 | 100 | 100 | 100% |
02-21-2024 | $3.55 | $3.55 | $3.55 | $3.55 | 1,030 | 1,000 | 97.09% |
02-20-2024 | $3.75 | $3.5 | $3.75 | $3.5 | 585 | 150 | 25.64% |
02-09-2024 | $3.99 | $3.84 | $3.99 | $3.84 | 200 | 100 | 50% |
02-06-2024 | $4.25 | $4.25 | $4.25 | $4.25 | 820 | 820 | 100% |
News, Short Squeeze, Breakout and More Instantly...
Saint Herblain (France), July 1, 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the European Commission (EC) has granted marketing authorization in Europe for Valneva’s single-dose vaccine, IXCHIQ ® , for the p...
Saint-Herblain (France), June 26, 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that all the resolutions recommended by the Board of Directors were approved by the shareholders at its Combined General Meeting (CGM) held today in L...
Saint-Herblain (France), June 24, 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that Health Canada has approved IXCHIQ ® , Valneva’s single-dose vaccine for the prevention of disease caused by the chikungunya virus...